LAS VEGAS, NV--(MARKET WIRE)--Aug 15, 2008 -- Emergency Filtration Products, Inc. (EFP) (Other OTC:EMFP.PK - News) today announced that it recently received a comment letter from the U.S. Food and Drug Administration (FDA) in connection with its 510(k) pre-market notification for the NanoMask TM that was filed on June 13, 2008.
“We are pleased to have received such a rapid review from the FDA and look forward to addressing their comments promptly,” said Philip Dascher, CEO, EFP. “Our FDA review team, comprised of EFP management and a number of expert FDA consultants, is gathering the information necessary to provide the FDA with the information that it needs to proceed.”
About EFP
EFP is a filtration technology company that has a unique and highly efficient hydrophobic antimicrobial silver nanoparticle coated medical air filter mask, the NanoMask, which is designed to reduce airborne pathogens on contact for diverse medical uses. EFP has recently submitted a 510(k) medical device notification with the FDA for its surgical NanoMask.
Safe Harbor Statement
This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP and ANI do not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the companies could differ significantly from such forward-looking statements.
Contact:
Contact: Investor Relations Philippe Niemetz PAN Consultants Ltd. 800-477-7570 212-344-6464 p.niemetz@panconsultants.com
Source: Emergency Filtration Products, Inc.
